Open Insider Trading Activity for Reshape Lifesciences Inc. Chief Financial Officer Stankovich Thomas
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting RSLS | 2024-08-13 | 2024-05-31 | Reshape Lifesciences Inc. | Stankovich Thomas | Chief Financial Officer | Sell | 4 | 172 | $0.23 | $38.78 | 0.19% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RSLS | 2023-07-06 | 2023-06-30 | Reshape Lifesciences Inc. | Stankovich Thomas | Chief Financial Officer | Buy | 1 | 17,702 | $1.52 | $26,907.04 | 75.36% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting RSLS | 2023-07-06 | 2023-05-31 | Reshape Lifesciences Inc. | Stankovich Thomas | Chief Financial Officer | Sell | 3 | 303 | $2.46 | $746.14 | 1.69% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting RSLS | 2022-10-06 | 2022-10-04 | Reshape Lifesciences Inc. | Stankovich Thomas | CFO | Sell | 2 | 8,293 | $0.28 | $2,322.04 | 1.21% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting RSLS | 2022-09-12 | 2022-09-06 | Reshape Lifesciences Inc. | Stankovich Thomas | Chief Financial Officer | Sell | 1 | 4,828 | $0.39 | $1,882.92 | 1.37% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting RSLS | 2022-03-02 | 2022-02-28 | Reshape Lifesciences Inc. | Stankovich Thomas | CFO | Sell | 1 | 3,658 | $1.06 | $3,877.48 | 1.02% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting RSLS | 2022-02-02 | 2022-01-31 | Reshape Lifesciences Inc. | Stankovich Thomas | Chief Financial Officer | Sell | 1 | 3,684 | $1.22 | $4,494.48 | 1.02% | View Filing |